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Abstract
Background: Therapeutic alliance (TA) has been found to be a significant predictor of outcome for patients with severe
and enduring anorexia nervosa (SE-AN), accounting for more variance than treatment type. To better understand how to
promote TA for this population, the aim of the current study was to investigate predictors of TA in adults with SE-AN.
Methods: Participants were 63 adult females with SE-AN presenting to an outpatient, multi-site randomized controlled
trial conducted at two clinical sites. Participants’ perception of the quality of their therapeutic relationship, demographic
information, and eating disorder symptomatology were assessed via interview and questionnaire measures.
Results: Baseline ratings of how successful participants believed treatment would be for them was the only variable to
significantly predict early (p = .01), mid (p = .009), and late treatment alliance (p = .03). No other variables investigated
predicted the quality of patient rated TA at any point in treatment (ps > .57).
Conclusions: Results suggest instilling hope in treatment outcome may enhance TA, and in turn, outcomes for patients
with SE-AN in outpatient therapy.
Keywords: Therapeutic alliance, Anorexia nervosa, Cognitive behavioral therapy, Specialist supportive clinical
management, Predictors
Background
Therapeutic alliance (TA) is a relational bond that de-
velops between a patient and clinician via collaborative
work and trust, as both endeavor to establish and ac-
complish treatment goals [1]. Cited as a critical non-
specific factor in the treatment of depression [2], TA has
been shown to predict outcomes across a variety of
treatments and disorders, including in chronic presenta-
tions [3–10]. In the treatment of eating disorders, TA is
often considered an important element of interventions,
but with mixed effect on treatment success [11–16].
TA has been shown to play a central role in preventing
premature treatment drop-out in an inpatient popula-
tion with anorexia nervosa (AN) [17, 18], with even ini-
tial impressions promoting treatment compliance [17].
Further, in a sample of adults with severe and enduring
anorexia nervosa (SE-AN), TA was found to be a signifi-
cant predictor of eating disorder symptoms at end of
treatment (EOT) and at follow-up [19]. Indeed, TA actu-
ally accounted for more of the variance in outcome than
treatment type. As such, correlates of TA are a critical
domain to explore for patients with SE-AN.
While TA is recognized as an important predictor of
treatment engagement, less is known about the factors
that may contribute to the development of a strong alli-
ance in patients with AN, particularly those with a se-
vere and enduring course of illness. Research within the
field of anxiety and depression indicates that patients
with more severe symptoms report poorer TA [20]; how-
ever, these associations between symptom severity and
TA have not been replicated in adults with bulimia ner-
vosa (BN) [21]. The quality of the therapeutic relation-
ship has been noted as worse in individuals with chronic
eating disorders [22], suggesting that duration of illness,
or number of previous treatment episodes may adversely
affect treatment engagement and TA. Additionally, when
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exploring psychotherapy processes, patient preconcep-
tions and expectations regarding improvement have
been found to be associated with stronger alliance and
better overall treatment outcomes [23, 24]. This finding
has been supported within a treatment trial for BN [21].
Further, there is recent evidence to suggest that positive
early symptom change may be responsible for enhancing
TA in patients with BN [11, 14]. Despite these findings,
there is still a dearth of research investigating whether,
and which, patient characteristics influence TA in SE-
AN. Greater understanding of patient characteristics that
may influence therapeutic alliance and treatment en-
gagement is needed to help clinicians identify specific
treatment adaptations that may be needed to better
tailor treatment to individual need.
The aim of this paper is to explore possible correlates
of TA that may be present, irrespective of treatment or
therapist variation. In line with previous research
highlighted above, we hypothesized that characteristics
associated with SE-AN (i.e., longer treatment duration,
increased severity, higher previous treatment episodes,
lower motivation and expectation of treatment success,
and lower body mass index) would predict poorer
participant-rated TA for adults with SE-AN.
Methods
This study is a secondary analysis of data from a ran-
domized clinical trial (RCT) conducted at two clinical
sites (The University of Sydney and St. George’s Hos-
pital, University of London), with a Data and Coordinat-
ing Center (The University of Chicago Medicine). The
RCT compared the efficacy of Cognitive Behavioral
Therapy for anorexia nervosa (CBT-AN) and Specialist
Supportive Clinical Management (SSCM) for a sample
of adults with SE-AN. Specific treatment effects have
been analysed and are reported in the main outcome
paper [25]. Participants received 30 individual, out-
patient treatment sessions provided over eight months.
Participants
Recruitment of participants occurred from July 2007 to
November 2010 through advertising to eating disorder
clinics, clinicians, and generic websites.
Participants were eligible for randomization if they met
the Diagnostic and Statistical Manual for Mental Disor-
ders, 4th Edition, Text Revision (DSM-IV-TR) [26] criteria
for AN, excluding criterion D (amenorrhea); had an illness
duration of at least 7 years; were at least 18 years of age;
and were female. Exclusion criteria included presenting
with a current manic episode or psychosis; current alcohol
or substance abuse or dependence; significant current med-
ical or neurological illness (including seizure disorder), with
the exception of nutrition-related alterations that are im-
pacted by weight; current engagement in psychotherapy
and being unwilling to suspend such treatment for the dur-
ation of their participation in the study; and plans to move
beyond commuting distance for the study site in the follow-
ing 12 months or not living within commuting distance to
the study site.
In compliance with the Institutional Review Boards
(IRB) of the two intervention sites and the data and co-
ordinating center, participants completed written in-
formed consent prior to assessment. In addition to IRB
approval, the trial was approved by the Human Research
Ethics Committee (approval number 02-2007/9669) and
was registered with the Australian New Zealand Clinical
Trials Registry (ACTRN12607000440426).
Treatments and therapists
Participants were randomized to either CBT-AN or
SSCM by a biostatistician independent from both inter-
vention sites. Randomization was conducted using
Ephron’s biased coin approach, stratified within sites by:
1) subtype of illness (Restrictive and Binge-Purge) and 2)
psychopharmacological medication status. Treatment
occurred in outpatient settings at The University of Syd-
ney and St. George’s Hospital, University of London.
Treatments and therapist characteristics are described in
detail in previous papers [25, 27].
Measures
Physical assessment
Participants were weighed in light, indoor clothing with
their shoes removed. Weight and height were measured
by a trained research assistant using a calibrated digital
or balance-beam scale and stadiometer, respectively, to
calculate body mass index (BMI = kg/m2).
Helping Relationships Questionnaire (HRQ)
The HRQ measures the patient’s perspective of the
therapist-patient relationship via an 11 self-report items
[28]. Items for the HRQ are rated on a 6-point likert
scale, ranging from -3 (“Strongly feel it is not true”) to
+3 (“Strongly feel it is true”). Total scores, computed by
summing all items, range from -33 to 33, with higher
total scores reflecting greater TA. The HRQ was admin-
istered at week two, mid-treatment, and EOT. Partici-
pant responses with missing items on the HRQ were
excluded from analyses involving HRQ total scores. The
HRQ has strong psychometrics and has been shown to
correlate with treatment outcome [29, 30].
The Eating Disorder Examination (EDE)
The EDE is a semi-structured investigator-based inter-
view measuring cognitive and behavioral symptoms re-
lated to eating disorders [31]. The EDE was used to
generate DSM-IV-TR diagnoses for an ED and to assess
the severity of symptomatology. Subscales include:
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Weight Concern, Shape Concern, Eating Concern, and
Restraint; global scores reflect the overall severity of ED
symptoms.
The Anorexia Nervosa Stages of Change Questionnaire
(ANSOCQ)
The ANSOCQ is a 20-item self-report questionnaire
assessing a patient’s readiness for recovery from AN,
with higher total scores reflecting greater readiness for
recovery [32].
The Treatment Suitability and Patient Expectations (TSPE)
The TSPE is a 2-item self-report questionnaire designed
to assess a patient’s belief regarding her expectation of im-
provement in her treatment assignment (“How successful
do you think your treatment here will be?”) and suitability
of her assigned treatment. The TSPE items are answered
using an 11-point scale ranging from 0 (not at all) to 10
(completely acceptable or extremely suitable). The TSPE
is given following the first therapy session, once the pa-
tient has met with her therapist and is aware of which
treatment to which she has been randomized. The patient
is asked to comment on “overall” improvement, rather
than improvement on any specific domains (e.g., weight
gain, quality of life). The TSPE has been utilized in mul-
tiple trials with patients with eating disorders [25, 33–35].
Cronbach’s alphas for the TSPE ranged from .75 to .92
over the assessment time points in this trial.
Assessment time points
The physical assessment, EDE and ANSOCQ were ad-
ministered at baseline (pre randomization), session 15,
and EOT. The HRQ and the TSPE were given following
the first therapy session, session 15, and EOT.
Data analysis
Stepwise multiple regressions were conducted to investi-
gate the predictive utility of patient motivation, believed
suitability of treatment, symptom severity, duration of
illness, number of previous specialist ED treatment ex-
periences, and BMI on early treatment alliance. Stepwise
multiple regressions were also conducted to investigate
the predictive power of the variables detailed above, as
well as early treatment alliance, on participant ratings of
mid and end of treatment alliance. An alpha level of .05
was used to provide maximum power to identify poten-
tial predictors of therapeutic alliance.
Post hoc analyses were conducted to better understand
the role of significant predictor(s) of TA. An independent
t-Test was used to examine any differences occurring
based on treatment assignment and a pearson correlation
was run to understand the predictor(s) relationship to out-
come. To determine if a significant meditational effect was
present among the significant predictor(s) of TA, TA, and
eating disorder symptom outcomes (defined by EDE glo-
bal score), the methodology outlined by Baron and Kenny
was utilized to evaluate if mediation was supported [36].
Results
A total of 63 participants were randomized to CBT-AN
(n = 31) or SSCM (n = 32). The range of age for study par-
ticipants was 20-62 (M = 33.4 ± 9.6), with duration of illness
ranging from 7 to 49 years (M = 16.6 ± 8.5). The mean BMI
for the sample was 16.2 (SD = 1.3, range = 11.8-18.5). The
majority of participants met criteria for AN restricting sub-
type (n = 47, 74.6 %). No significant differences on any
baseline characteristics were found between treatment
groups, sites, or group-by-site interactions [25]. Table 1
shows baseline demographics for all predictor variables.
Baseline ratings of how successful participants believed
treatment would be was the only variable to significantly
predict early (β = 0.67, SE = 0.94, p = .01), mid (β = 0.80,
SE = 0.80, p = .009), and late treatment alliance (β = 0.66,
SE = 1.98, p = .03; see Table 2). Motivation, symptom
severity, duration of illness, age, number of previous spe-
cialist ED treatment experiences, early therapeutic alli-
ance, and BMI did not significantly predict alliance at
any point in treatment (ps > .57; see Table 3).
Patient expectations of treatment success
Participant ratings of anticipated treatment success did
not significantly differ based on treatment assignment
(CBT-AN M = 7.04 ± 1.97, SSCM M = 7.17 ± 1.56, p = .78).
The TSPE item was significantly correlated with EOT
(r(47) = -.40, p = .005) and follow-up (r(44) = -.48, p = .001)
EDE global scores.
Mediation analyses
Given the present findings that anticipated treatment
success significantly predicted TA, and past findings
from this sample indicating TA as a significant predictor
of outcome [19], additional analyses were conducted to
determine the possibility of a mediating relationship,
such that expectations for therapy impacts overall TA,
which impacts treatment outcomes (see Fig. 1). Utilizing
Baron and Kenny’s (1986) four step approach, a full
mediation effect is suggested for early TA, such that:
step 1) expectations of treatment success (TSPE item 2)
significantly predicts EOT symptomology (EDE global
score; p = .005); step 2) expectations of treatment success
(TSPE item 2) significantly predicts early TA (p < .001);
step 3) early TA significantly predicts EOT symptomol-
ogy (p = .02); and step 4) expectations of treatment suc-
cess no longer significantly predicts EOT symptomology
after controlling for early TA (p = .07) [36]. A partial me-
diation effect is suggested for late TA, such that: step 1)
expectations of treatment success significantly predicts
EOT symptomology (p = .005); step 2) expectations of
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treatment success significantly predicts late TA (p < .02);
step 3) late TA significantly predicts EOT symptomology
(p = .002); and step 4) expectations of treatment success
significantly predicts EOT symptomology after control-
ling for early TA (ps = .03).
Discussion
This study examined predictors of TA in a treatment
trial offering two psychological therapies for SE-AN.
Contrary to our hypotheses, nearly all of the variables
examined were not found to be significant predictors of
TA at the start of treatment, mid treatment, or EOT. In-
deed, patient expectations for treatment, an item in the
TSPE which was given following the first therapy ses-
sion, was found to be the only significant predictor of
TA throughout treatment. Mediation analyses suggested
that this early treatment factor impacts outcomes such
that patient treatment expectations drive the develop-
ment of TA, which impacts treatment outcomes.
These findings are in contrast to previous research
suggesting that increased duration of illness, severity of
illness, and decreased motivation may have a negative
impact on TA [3, 20–22]. A number of recent studies
confirm the difficulties in engaging individuals with SE-
AN in psychological treatments [37–39]. This has likely
contributed to a prejudice that may be held by many
treating clinicians, both in their own expectations for
outcome as well as their belief that patients with SE-AN
are not interested in positive treatment outcomes. How-
ever, it appears that within this sample, illness duration,
illness severity, previous failed treatment experiences,
and baseline BMI had no significant predictive capacity
on patients’ therapeutic relationships. While this study
did not include patients with a short duration of AN,
reported levels of TA in the current study were consist-
ent with the use of the HRQ with other samples with
eating disorders [33]. As such, clinicians should remain
highly cautious when assuming that illness character-
istics can impact the likelihood of forming an engage-
ment. Additionally, this study found that early TA had
little predictive validity on later TA ratings. This sug-
gests that when initial impressions are made, other
factors may override them and have a greater influ-
ence on the strength of the therapeutic relationship as
treatment progresses.
Patients’ belief in the ability of the treatment to con-
tribute to overall improvement of symptoms was the
only significant contributor to their experience of TA at
all stages of treatment. This finding is consistent with
the literature on adults with BN [21], and longstanding
work noting the importance of hope and alliance in
treatments [40]. Further, it suggests that clinicians
attempting to engage patients with SE-AN in meaningful
psychological work should focus early in treatment on
Table 1 Baseline characteristics of predictor variables for therapeutic alliance
Variable Mean Standard Deviation Range (Minimum, Maximum)
Age 33.41 9.57 42 (20, 62)
Duration of Illness 16.57 8.45 42 (7, 49)
ANSOCQ 16.57 17.89 77 (0, 77)
BMI 16.20 1.34 6.67 (11.80, 18.47)
EDE Global Score 3.10 1.31 5.26 (.41, 5.67)
Frequency of Specialist ED Interventions 6.80 4.16 16 (2, 18)
TSPE: Suitability of Treatment 7.41 1.78 9 (1, 10)
TSPE: Success of Treatment 7.08 1.75 9 (1, 10)
Note. ANSOCQ = The Anorexia Nervosa Stages of Change Questionnaire; BMI = Body Mass Index; EDE = Eating Disorders Examination; ED = Eating Disorders; TSPE =
Treatment Suitability and Patient Expectations
Table 2 Significant predictors of therapeutic alliance determined through stepwise regression
Stepwise regression variable ΔR2 ΔF B SE Β p
Early Treatment Alliance Model
Baseline Rating of Anticipated Treatment Success .45 8.97 2.83 0.94 .67 .01
Mid Treatment Alliance Model
Baseline Rating of Anticipated Treatment Success .64 12.68 2.86 0.80 .80 .009
Late Treatment Alliance Model
Baseline Rating of Anticipated Treatment Success .44 7.09 5.27 1.98 .66 .03
Note. Variables excluded for early treatment alliance model: number of previous specialist eating disorder interventions, baseline motivation score, duration of
illness, age, baseline Body Mass Index (BMI), rating of treatment suitability, and baseline eating disorder severity (ps > .68); variables excluded for mid and end of
treatment alliance models: early treatment rating of therapeutic alliance, number of previous specialist eating disorder interventions, baseline motivation score,
duration of illness, age, baseline BMI, rating of treatment suitability, and baseline eating disorder severity (ps > .57)
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bolstering patient expectations about the intervention
they are undertaking. This may include providing psy-
choeducation regarding the efficacy of CBT-AN and
SSCM for SE-AN [25], or the benefits of symptom
change even when remission is not possible [27]. Where
available, these early treatment actions may aid the
process of building a positive TA throughout treatment,
which in turn supports better outcomes [19, 41]. Indeed,
as more research is conducted to identify the most ef-
fective means to treat adults with SE-AN, bolstering TA
is a likely channel to improve outcomes for currently
available treatments [42].
To our knowledge, this is the first study to examine
predictors of TA in a sample of SE-AN. Engagement in
treatments for SE-AN remains a struggle for clinicians.
Therefore, examining predictors of TA as a means to en-
hance the likelihood of forming a positive TA is crucial.
There were several strengths to this study, including
assessments with well-validated measures. Despite these
strengths, limitations should be considered in the inter-
pretation of these findings. While the sample sizes were
sufficient to show differences in outcomes, they were
also moderate in size. Further, despite its use across a
number of RCTs [25, 33–35], the two-item TSPE re-
mains unvalidated. The TSPE was also administered fol-
lowing the first session, which means it is possible that
patient expectations were also influenced by the rapport
experienced with the therapist during the first session.
For this reason, we are cautious to over interpret these
findings until they can be confirmed in future research
examining treatment expectation prior to meeting the
therapist. Additionally, this sample includes only individ-
uals with SE-AN. While it remains unclear how these re-
sults generalize to individuals with a shorter duration or
less severe presentations, the authors see this as a future
research question, rather than a limitation of the study.
It is also of note that the number of analyses conducted
increases the risk for Type I error. Future studies should
Table 3 Variables excluded as significant predictors of therapeutic
alliance determined through stepwise regression
Stepwise regression variable Beta In t p
Early Treatment Alliance Model
Previous specialist ED intervention .362 1.73 .12
Baseline ANSOQC Total .142 .57 .58
Duration of illness -.052 -.22 .83
Age -.026 -.11 .92
Baseline BMI -.173 -.72 .49
Baseline rating of treatment suitability .278 1.03 .33
Baseline EDE Global score -.039 -.17 .87
Mid Treatment Alliance Model
Previous specialist ED intervention .119 .49 .64
Baseline ANSOQC Total .366 1.64 .15
Duration of illness -.353 -1.70 .14
Age -.435 -1.81 .12
Baseline BMI -.403 -1.63 .16
Baseline rating of treatment suitability -.225 -.74 .49
Baseline EDE Global score -.281 -1.26 .25
Early Treatment HRQ Total .087 .27 .80
Late Treatment Alliance Model
Previous specialist ED intervention -.091 -.34 .74
Baseline ANSOQC Total -.176 -.61 .56
Duration of illness -.229 -.86 .41
Age -.021 -.07 .95
Baseline BMI .300 .98 .36
Baseline rating of treatment suitability -.147 -.44 .67
Baseline EDE Global score -.049 -.18 .86
Early Treatment HRQ Total .205 .66 .53
Note. ED = Eating Disorder; ANSOQC = The Anorexia Nervosa Stages of Change
Questionnaire; BMI = Body Mass Index; EDE = Eating Disorders Examination;
HRQ = Helping Relationships Questionnaire
Fig. 1 Therapeutic alliance mediates the relationship between treatment expectations and outcome
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explore predictors of TA in larger samples, including
both individuals with BN and with patients with a
shorter duration of AN. This would also exclude the
possibility of any floor effects influencing the non-
significant finding for duration of illness arising from the
chronic nature of this group. It may also be beneficial to
explore patient characteristics in conjunction with ther-
apist characteristics.
Conclusions
Results of this study suggest that an initial patient ex-
pectation for successful outcome significantly predicts
patient-reported TA throughout treatment. Further, a
mediational relationship between early patient treatment
expectations, TA, and outcomes appears to exist for this
sample of adults with SE-AN. Most cases of SE-AN are
defined for clinicians by patients’ egosyntonic wish to
preserve maladaptive behaviors that they identify as hav-
ing a “functional” purpose [37]. Through this lens, thera-
peutic relationships can at times be sacrificed, regardless
of chronicity. However, recent findings show that posi-
tive and strong TA can be established in individuals with
SE-AN [19]. The present study expands insight into TA
for individuals with SE-AN, demonstrating that TA can
be bolstered with early treatment expectations for suc-
cessful treatment.
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